Key result
Neuropathogenic LDV-C and nonneuropathogenic LDV-P coexist in virus pools, and LDV-C exhibits a reduced ability to establish persistent infection in peripheral tissues compared to LDV-P.
Neuropathogenic LDV variants have a reduced ability to establish persistent infection in peripheral tissues compared to nonneuropathogenic variants, likely due to higher sensitivity to antibody neutralization.
Answers are grounded in this paper and cite their sources.
May limit neuropathogenic spread via antibody sensitivity; leaves open mechanisms of variant selection in animal models.
Neuropathogenic isolates of lactate dehydrogenase-elevating virus (LDV) differ from nonneuropathogenic isolates in their unique ability to infect anterior horn neurons of immunosuppressed C58 and AKR mice and cause paralytic disease (age-dependent poliomyelitis [ADPM]). However, we and others have found that neuropathogenic LDVs fail to retain their neuropathogenicity during persistent infections of both ADPM-susceptible and nonsusceptible mice. On the basis of a segment in open reading frame 2 that differs about 60% between the neuropathogenic LDV-C and the nonneuropathogenic LDV-P, we have developed a reverse transcription-PCR assay that distinguishes between the genomes of the two LDVs and detects as little as 10 50% infectious doses (ID50) of LDV. With this assay, we found that LDV-P and LDV-C coexist in most available pools of LDV-C and LDV-P. For example, various plasma pools of 10(9.5) ID50 of LDV-C/ml contained about 10(5) ID50 of LDV-P/ml. Injection of such an LDV-C pool into mice of various strains resulted in the rapid displacement in the circulation of LDV-C by LDV-P as the predominant LDV, but LDV-C also persisted in the mice at a low level along with LDV-P. We have freed LDV-C of LDV-P by endpoint dilution (LDV-C-EPD). LDV-C-EPD infected mice as efficiently as did LDV-P, but its level of viremia during the persistent phase was only 1/10,000 that observed for LDV-P. LDV-permissive macrophages accumulated and supported the efficient replication of superinfecting LDV-P. Therefore, although neuropathogenic LDVs possess the unique ability to infect anterior horn neurons of ADPM-susceptible mice, they exhibit a reduced ability to establish a persistent infection in peripheral tissues of mice regardless of the strain. The specific suppression of LDV-C replication in persistently infected mice is probably due in part to a more efficient neutralization of LDV-C than LDV-P by antibodies to the primary envelope glycoprotein, VP-3P. Both neuropathogenicity and the higher sensitivity to antibody neutralization correlated with the absence of two of three N-linked polylactosaminoglycan chains on the ca. 30-amino-acid ectodomain of VP-3P, which seems to carry the neutralization epitope(s) and forms part of the virus receptor attachment site.
No takes yet. Share an insight, caveat, or question.
Chen et al. (1997) studied Lactate dehydrogenase-elevating virus (LDV) infection. Lactate dehydrogenase-elevating virus (LDV) variants (LDV-C and LDV-P) was evaluated on Coexistence and persistence of LDV variants. Neuropathogenic LDV-C and nonneuropathogenic LDV-P coexist in virus pools, and LDV-C exhibits a reduced ability to establish persistent infection in peripheral tissues compared to LDV-P.
Synapse has enriched 10 related papers. Consider them for comparative context: